BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28111259)

  • 1. Critical role of Keratin 1 in maintaining epithelial barrier and correlation of its down-regulation with the progression of inflammatory bowel disease.
    Dong X; Liu Z; Lan D; Niu J; Miao J; Yang G; Zhang F; Sun Y; Wang K; Miao Y
    Gene; 2017 Apr; 608():13-19. PubMed ID: 28111259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
    Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
    Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratin 1 maintains the intestinal barrier in ulcerative colitis.
    Wu J; Niu J; Li M; Miao Y
    Genes Genomics; 2021 Dec; 43(12):1389-1402. PubMed ID: 34562265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCAT1 lncRNA Promotes Inflammatory Bowel Disease Malignancy by Destroying Intestinal Barrier via Downregulating miR-185-3p.
    Ma D; Cao Y; Wang Z; He J; Chen H; Xiong H; Ren L; Shen C; Zhang X; Yan Y; Yan T; Guo F; Xuan B; Cui Z; Ye G; Fang JY; Chen H; Hong J
    Inflamm Bowel Dis; 2019 Apr; 25(5):862-874. PubMed ID: 30615124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new role for reticulon-4B/NOGO-B in the intestinal epithelial barrier function and inflammatory bowel disease.
    Rodríguez-Feo JA; Puerto M; Fernández-Mena C; Verdejo C; Lara JM; Díaz-Sánchez M; Álvarez E; Vaquero J; Marín-Jiménez I; Bañares R; Menchén L
    Am J Physiol Gastrointest Liver Physiol; 2015 Jun; 308(12):G981-93. PubMed ID: 25907690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial tight junctions in intestinal inflammation.
    Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
    Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1.
    Fischer A; Gluth M; Weege F; Pape UF; Wiedenmann B; Baumgart DC; Theuring F
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G218-28. PubMed ID: 24309183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Bacillus subtilis on Epithelial Tight Junctions of Mice with Inflammatory Bowel Disease.
    Gong Y; Li H; Li Y
    J Interferon Cytokine Res; 2016 Feb; 36(2):75-85. PubMed ID: 26720180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid rafts are disrupted in mildly inflamed intestinal microenvironments without overt disruption of the epithelial barrier.
    Bowie RV; Donatello S; Lyes C; Owens MB; Babina IS; Hudson L; Walsh SV; O'Donoghue DP; Amu S; Barry SP; Fallon PG; Hopkins AM
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G781-93. PubMed ID: 22241861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Bowel Disease Susceptibility Gene
    Manzanillo P; Mouchess M; Ota N; Dai B; Ichikawa R; Wuster A; Haley B; Alvarado G; Kwon Y; Caothien R; Roose-Girma M; Warming S; McKenzie BS; Keir ME; Scherl A; Ouyang W; Yi T
    Immunohorizons; 2018 May; 2(5):164-171. PubMed ID: 31022698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Qing Hua Chang Yin on lipopolysaccharide‑induced intestinal epithelial tight junction injury in Caco‑2 cells.
    Fang W; Zhao P; Shen A; Liu L; Chen H; Chen Y; Peng J; Sferra TJ; Sankararaman S; Luo Y; Ke X
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells.
    Fischer A; Gluth M; Pape UF; Wiedenmann B; Theuring F; Baumgart DC
    Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G970-9. PubMed ID: 23538493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of cellular prion protein for intestinal barrier function and mislocalization in patients with inflammatory bowel disease.
    Petit CS; Barreau F; Besnier L; Gandille P; Riveau B; Chateau D; Roy M; Berrebi D; Svrcek M; Cardot P; Rousset M; Clair C; Thenet S
    Gastroenterology; 2012 Jul; 143(1):122-32.e15. PubMed ID: 22446194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium/Ask1/MKK7/JNK2/c-Src signalling cascade mediates disruption of intestinal epithelial tight junctions by dextran sulfate sodium.
    Samak G; Chaudhry KK; Gangwar R; Narayanan D; Jaggar JH; Rao R
    Biochem J; 2015 Feb; 465(3):503-15. PubMed ID: 25377781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Layered defense: how mucus and tight junctions seal the intestinal barrier.
    Capaldo CT; Powell DN; Kalman D
    J Mol Med (Berl); 2017 Sep; 95(9):927-934. PubMed ID: 28707083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation.
    Rankin CR; Lokhandwala ZA; Huang R; Pekow J; Pothoulakis C; Padua D
    Life Sci; 2019 Aug; 231():116571. PubMed ID: 31207308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.
    Terc J; Hansen A; Alston L; Hirota SA
    Eur J Pharm Sci; 2014 May; 55():12-9. PubMed ID: 24486481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
    Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
    Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild jujube polysaccharides protect against experimental inflammatory bowel disease by enabling enhanced intestinal barrier function.
    Yue Y; Wu S; Li Z; Li J; Li X; Xiang J; Ding H
    Food Funct; 2015 Aug; 6(8):2568-77. PubMed ID: 26114600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.